Kura Oncology, Inc. (KURA)

Kura Oncology Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-152.63	-135.84	-130.47	-89.63	-63.14
Depreciation & Amortization	0.85	0.76	0.56	0.19	0
Share-Based Compensation	28.08	26.32	23.58	12.81	9.41
Other Operating Activities	-1.12	-1.3	1.78	6.79	-1.03
Operating Cash Flow	-124.82	-110.06	-104.55	-69.83	-54.76
Capital Expenditures	-0.17	-0.63	-1.15	-2.17	0
Change in Investments	15.73	33.25	-125.69	-97.77	-46.33
Investing Cash Flow	15.56	32.63	-126.84	-99.94	-46.33
Share Issuance / Repurchase	94.78	29.14	4.43	469.58	111.1
Debt Issued / Paid	0	9.43	-7.86	-0.25	0
Financing Cash Flow	94.78	38.57	-3.44	469.33	111.1
Net Cash Flow	-14.48	-38.87	-234.82	299.57	10.02
Free Cash Flow	-124.99	-110.69	-105.7	-72	-54.76
Free Cash Flow Per Share	-1.71	-1.65	-1.59	-1.36	-1.30

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).